FATE

FATE THERAPEUTICS INC

Healthcare | Micro Cap

-$0.28

EPS Forecast

$1.78

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.28

Revenue Forecast:

$1.78

EPS Surprise Forecast:

$0.016

Revenue Surprise Forecast:

$0

Post-release price volatility - High

Post-release Overnight Move:

±8.9%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

61%

Probability of beating revenue consensus:

53%

Probability of beating both EPS & revs consensus:

38%

Probability of missing both EPS & revs consensus:

24%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.05

Revenue standard deviation:

$3

As % of share price:

5.08% EXTREME UNCERTAINTY

As % of market cap:

2.14% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.22

Revenue 95th %ile:

$5

EPS 75th %ile:

-$0.26

Revenue 75th %ile:

$3

EPS 25th %ile:

-$0.30

Revenue 25th %ile:

$1

EPS 5th %ile:

-$0.35

Revenue 5th %ile:

-$1

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

90% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$190

Bid-ask per Share:

$0.02